Recent news

Archived news

New scientific publication, defining a new bacteriophage genus TP84 virus. The paper describes monographic work on TP-84 bacteriophage genomics, bioinformatics and proteomics analysis leading to the construction of a new thermostable, nanobiocarrier for bioactive molecules. Moreover, this work is important from basic research stand point. Because the genome sequence shows essentially no similarity to any previously characterised bacteriophage, TP-84 should be considered a new species in an undefined genus within the Siphoviridae family. Thus a taxonomic proposal of a new Tp84virusgenus has been accepted by the International Committee on Taxonomy of Viruses. The results were published in PLOS ONE: Skowron PM et. al.:: “Sequence, genome organization, annotation and proteomics of the thermophilic, 47.7-kb Geobacillus stearothermophilus bacteriophage TP-84 and its classification in the new Tp84virus genus.” PLOS ONE 2018, 13: e0195449.

Thermostable proteins bioprocesses...
Download PD • 6.32MB

Our company and team members are environmentally conscious. BioVentures Institute patented technology has potentially high impact on the environment monitoring, remediation and protection. Continuing +!5 years cooperation with Malaysian biotechnology holding Revongen Corporation there was founded ClearWing Foundation for Biodiversity ( The foundation was established by two funders: BioVentures Institute President - professor Piotr Skowron and Revongen President – Mr El Law as well as Italian nature movie maker – Mr Paolo Volponi (the foundation President) and recognised entomologist – dr Marta Skowron Volponi (the Foundation vice-President). The foundation is actively persuing biodiversity exploration, which has resulted in discovery of 5 new butterfly species in Malaysia and Thailand as well as rediscovery of Asian butterfly species, which was considered extinct for 130 years. This dr Marta Skowron Volponi discovery was commented wordwide, including Science magazine (

BioVentures InstituteSp. z o.o. continues a long term cooperation with University of Gdansk and New England Biolabs Ltd. (USA), a world leader in the development and sales of enzymatic tools for recombinant DNA technologies. Our common project in the field of restriction endonucleases has resulted in solving a longstanding riddle of two RM.TaqII specificities, discovering a third RM system (RM.TaqIII) from T. aquaticus YT-1. Results were published in a high Impact Factor (10.2) journal – Nucleic Acid Research 2017, DOI: 10.1093/nar/gkx599. Among the authors is a Nobel Prize Nominee – prof. Richard Roberts..

The third restriction–modification syste
Download • 12.16MB